Review Article

Novel Uses for Lipid-Lowering Agents

Megan Brafford May, PharmD, BCOP, and Ashley Glode, PharmD, BCOP

Baptist Health Lexington, Lexington, Kentucky; University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado

Megan Brafford May, PharmD, BCOP, Baptist Health Lexington, 1740 Nicholasville Road, Lexington, KY 40503.
E-mail: megan.may@bhsi.com

Authors’ disclosures of potential conflicts of interest are found at the end of this article.


J Adv Pract Oncol 2016;7:181–187 | doi: 10.6004/jadpro.2016.7.2.4 | © Harborside Press 2016


  

ABSTRACT

Abstract

Statin use leads to a reduction in the downstream products of the mevalonate pathway. Knowledge of this pathway has led scientists to investigate the role of statins in cancer prevention and treatment. Statins appear to possess a variety of pleiotropic effects, including inhibition of cell proliferation; enhanced apoptosis; and modulation of inflammation, endothelial function, and angiogenesis. In cancer specifically, experimental studies have found that statins may induce cancer cell apoptosis and inhibit tumor growth, angiogenesis, and metastasis. These mechanisms have steered researchers into evaluating the possible benefit of statins in the prevention and treatment of malignancies. This review will discuss the literature supporting the use of statins to prevent and treat cancer.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here